📚 Lecture Overview
This lecture covers major central nervous system (CNS) parasitic infections, focusing on cerebral malaria, African trypanosomiasis, and toxoplasmosis. It highlights their pathogenesis, key diagnostic features across peripheral blood and tissue sites, and therapeutic strategies tailored to specific patient populations (e.g., pregnant vs. immunocompromised individuals). Mastery of these protozoan infections is essential for diagnosing encephalopathies and selecting proper antimicrobial protocols.
🎯 Key Concepts & Definitions
- Cerebral Malaria: A severe, life-threatening complication of malaria and the most common nontraumatic encephalopathy worldwide.
- Sequestration: The process where parasite-infected red blood cells adhere to tissue capillary walls, preventing them from circulating in peripheral blood.
- Variant Surface Glycoprotein (VSG): A surface coat protein on trypanosomes that undergoes continuous antigenic variation to evade host immune defenses.
- Glossina: The tsetse fly vector responsible for transmitting African trypanosomiasis.
- Spiramycin: A specific antimicrobial agent used in pregnant patients with toxoplasmosis to prevent transmission to the fetus.
📖 Main Content
1. Cerebral Malaria
- Epidemiology:
- Causes approximately 10,000 cases annually.
- Recognized as the most common nontraumatic encephalopathy.
- Pathogenesis & CNS Involvement:
- Parasites enter systemic circulation and traverse pathways to reach and affect brain tissues.
- Diagnostic Evaluation:
- Blood Film: Distinguishes between parasite stages circulating in peripheral blood and stages sequestered in tissue capillaries.
- Neuroimaging Findings: Key radiological features include cerebral oedema and cerebral haemorrhage.
2. African Trypanosomiasis
- Vector: Transmitted via the bite of the Glossina (Tsetse fly).
- Immune Evasion: Utilizes Variant surface glycoprotein (VSG) to continually change its surface antigens and escape immune clearance.
- Diagnostic Identification:
- Blood Film: Used to identify and count trypomastigotes.
- Tissue Localization: Trypomastigotes are evaluated in blood as well as other body sites/fluids.
3. Toxoplasmosis Management
Treatment protocols are stratified according to the patient's immune and pregnancy status:
| Clinical Group | Primary Management Strategy |
|---|---|
| Pregnant Women | Spiramycin |
| Immunocompromised Patients | Pyrimethamine + Folinic acid + Sulfadiazine (or Clindamycin) |
| HIV / Immunocompromised Support | Cotrimoxazole and HAART (Highly Active Antiretroviral Therapy) |
📊 Visual Learning
💡 Important Points to Remember
- Cerebral malaria accounts for 10,000 cases annually and is the most common nontraumatic encephalopathy.
- Sequestered stages of malaria parasites lodge within tissue microvasculature/capillaries and are not observed on peripheral blood smears.
- Diagnostic neuroimaging of cerebral malaria characteristically reveals cerebral oedema and cerebral haemorrhage.
- Glossina (tsetse fly) is the vector for African trypanosomiasis.
- The principal mechanism of immune evasion in trypanosomiasis is antigenic variation via Variant Surface Glycoprotein (VSG).
- Trypomastigotes are the main diagnostic stage sought in blood films and secondary fluid/tissue locations.
- Spiramycin is strictly indicated for treating toxoplasmosis in pregnant patients to protect the fetus.
- The standard regimen for toxoplasmosis in immunocompromised patients is Pyrimethamine + Folinic acid + Sulfadiazine (or Clindamycin).
- Folinic acid must always accompany pyrimethamine therapy to prevent hematologic toxicity.
- Cotrimoxazole and HAART play essential roles in prophylactic and adjunct management for immunocompromised individuals.
⚠️ Common Exam Questions
Exam Traps & Examiner Tricks:
- Peripheral Smear vs. Sequestered Stages: Examiners frequently test why a peripheral blood film might not reflect the full parasite load in cerebral malaria.
- Trap: Expecting all parasitic stages to be visible in peripheral blood.
- Fact: Mature forms undergo sequestration in tissue capillaries, meaning only specific stages appear in peripheral smears.
- Toxoplasmosis Drug Selection in Pregnancy: Questions often ask for the treatment of toxoplasmosis in a pregnant female.
- Trap: Including Pyrimethamine in the choices to distract students.
- Fact: Spiramycin is the correct choice during pregnancy to prevent fetal transmission without causing teratogenicity.
- Purpose of Folinic Acid: A common short-answer question asks why Folinic acid is added to the Pyrimethamine/Sulfadiazine combination.
- Fact: It is co-administered specifically to protect host bone marrow from pyrimethamine-induced folate deficiency.
- Antigenic Evasion Mechanism: MCQs regarding African Trypanosomiasis usually target the specific structure responsible for immune evasion.
- Fact: Always select Variant Surface Glycoprotein (VSG).
📝 Quick Review Checklist
I can recall the epidemiology of cerebral malaria (10,000 cases/year, most common nontraumatic encephalopathy).
I understand the concept of parasite sequestration in tissue capillaries.
I can list the key imaging findings of cerebral malaria (cerebral oedema and haemorrhage).
I can name the vector (Glossina) and immune evasion protein (VSG) of trypanosomiasis.
I know where trypomastigotes can be identified diagnostically.
I can select Spiramycin as the treatment for toxoplasmosis in pregnant patients.
I know the drug combination for immunocompromised toxoplasmosis patients (Pyrimethamine + Folinic acid + Sulfadiazine/Clindamycin).
I understand the roles of Cotrimoxazole and HAART in immunocompromised regimens.